Skip to main content
. 2024 Mar 11;13(3):1508–1518. doi: 10.21037/tcr-23-1333

Figure 4.

Figure 4

Kaplan-Meier curves of progression-free survival (A) and overall survival (B) of advanced hepatocellular carcinoma receiving combination treatment of pembrolizumab plus bevacizumab plus intrahepatic hepatocellular carcinoma-directed external beam moderately hypo-fractionated radiotherapy. CI, confidence interval.